RPRX NASDAQ
Royalty Pharma plc
1W: -1.8%
1M: -9.4%
3M: +0.4%
YTD: +47.9%
1Y: +58.2%
3Y: +127.9%
5Y: +70.8%
$57.16
-0.47 (-0.82%)
Weekly Expected Move ±3.2%
$53
$55
$57
$59
$61
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2023-10-19
Earliest Filing
2025-12-29
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named RPRX in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| PTCT PTC THERAPEUTICS, INC. | partner | Named as a party to the Amendment regarding the sale of royalty interests. | 2025-12-29 | View |
| ZBIO Zenas BioPharma, Inc. | partner | Counterparty to a Revenue Participation Right Purchase and Sale Agreement regarding potential milestone payments for the | 2025-10-08 | View |
| PTCT PTC THERAPEUTICS, INC. | partner | Named party in the amended royalty purchase agreement | 2023-10-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-06-04 | Shareholder Vote | View | |
| 2026-05-28 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-04-13 | Regulation FD | View | |
| 2026-02-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-22 | Regulation FD Disclosure | View | |
| 2025-12-22 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-16 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-08-13 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-19 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creati | Agreement Acquisition | View |
| 2025-05-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-11 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-04-10 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-02-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR